CLDX
Price
$24.93
Change
-$0.65 (-2.54%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
1.7B
103 days until earnings call
Intraday BUY SELL Signals
FDMT
Price
$10.81
Change
+$0.72 (+7.14%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
575.92M
100 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLDX vs FDMT

Header iconCLDX vs FDMT Comparison
Open Charts CLDX vs FDMTBanner chart's image
Celldex Therapeutics
Price$24.93
Change-$0.65 (-2.54%)
Volume$11.59K
Capitalization1.7B
4D Molecular Therapeutics
Price$10.81
Change+$0.72 (+7.14%)
Volume$25.87K
Capitalization575.92M
CLDX vs FDMT Comparison Chart in %
CLDX
Daily Signal:
Gain/Loss:
FDMT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CLDX vs. FDMT commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Hold and FDMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (CLDX: $25.58 vs. FDMT: $10.08)
Brand notoriety: CLDX and FDMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 52% vs. FDMT: 122%
Market capitalization -- CLDX: $1.66B vs. FDMT: $617.63M
CLDX [@Biotechnology] is valued at $1.66B. FDMT’s [@Biotechnology] market capitalization is $617.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileFDMT’s FA Score has 0 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • FDMT’s FA Score: 0 green, 5 red.
According to our system of comparison, both CLDX and FDMT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 6 TA indicator(s) are bullish while FDMT’s TA Score has 3 bullish TA indicator(s).

  • CLDX’s TA Score: 6 bullish, 4 bearish.
  • FDMT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than FDMT.

Price Growth

CLDX (@Biotechnology) experienced а +4.99% price change this week, while FDMT (@Biotechnology) price change was -6.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

CLDX is expected to report earnings on Mar 02, 2026.

FDMT is expected to report earnings on Feb 27, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.7B) has a higher market cap than FDMT($576M). FDMT YTD gains are higher at: 80.969 vs. CLDX (1.247). FDMT has higher annual earnings (EBITDA): -213.2M vs. CLDX (-231.4M). CLDX has more cash in the bank: 630M vs. FDMT (293M). CLDX has less debt than FDMT: CLDX (3.03M) vs FDMT (23.1M). CLDX has higher revenues than FDMT: CLDX (5.79M) vs FDMT (33K).
CLDXFDMTCLDX / FDMT
Capitalization1.7B576M295%
EBITDA-231.4M-213.2M109%
Gain YTD1.24780.9692%
P/E RatioN/AN/A-
Revenue5.79M33K17,545%
Total Cash630M293M215%
Total Debt3.03M23.1M13%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
40

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDXFDMT
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
78%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CLDX
Daily Signal:
Gain/Loss:
FDMT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SDGAX132.01N/A
N/A
DWS Capital Growth A
DDIAX15.96N/A
N/A
Macquarie Wealth Builder A
TISAX73.29N/A
N/A
Nuveen S&P 500 Index I
HSCVX12.15N/A
N/A
Hunter Small Cap Value I
IRVIX26.43-0.07
-0.26%
Voya Russell Large Cap Value Idx Port I

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with XNCR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
-1.60%
XNCR - CLDX
53%
Loosely correlated
+2.62%
BEAM - CLDX
53%
Loosely correlated
-0.36%
CRNX - CLDX
53%
Loosely correlated
-1.17%
NRIX - CLDX
52%
Loosely correlated
-1.02%
IRON - CLDX
51%
Loosely correlated
+0.10%
More

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with RGNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
-7.95%
RGNX - FDMT
46%
Loosely correlated
+0.94%
IMTX - FDMT
43%
Loosely correlated
+8.99%
CLDX - FDMT
42%
Loosely correlated
-1.60%
IDYA - FDMT
42%
Loosely correlated
+1.08%
RCUS - FDMT
42%
Loosely correlated
+1.00%
More